Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial - Egyptian Knowledge Bank - troweb

424408

Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial

Article

Last updated: 27 Apr 2025

Overview Similar Items

Article

IMPACT OF LETROZOLE TREATMENT ON LIPID PROFILE IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER: A PROSPECTIVE STUDY

Article

Exploring Synergistic Effects of Combined Chemotherapeutic and Statin Therapy in Triple-Negative Breast Cancer

Article

Letrozole and Anastrozole in Early Breast Cancer Post-menopausal Patients in Oncology Department at Suez Canal University Hospital

Article

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

Article

Tamoxifen versus Tamoxifen and Ovarian Suppression in Premenopausal Hormone Positive early Breast Cancer (Retrospective study)

Article

Added Metformin to Systematic Neoadjuvant Chemotherapy in Breast Cancer Patients: Randomized Study from Egypt

Article

HER-2 LOW NON-METASTATIC BREAST ‎CANCER A CLINICO PATHOLOGICAL STUDY

Article

Letrozole versus tamoxifen for ovulation induction in non-polycystic ovarian syndrome anovulatory infertile females

Article

Metformin improves the therapeutic effect of metronomic cyclophosphamide in breast cancer animal model

Article

Role of Metformin in Combination with Trastuzumab and Neoadjuvant Chemotherapy in Treatment of HER-2 Positive Breast Cancer